Correction to: Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study.

Everts-Graber, Judith; Bonel, Harald; Lehmann, Daniel; Gahl, Brigitta; Häuselmann, HansJörg; Studer, Ueli; Ziswiler, Hans-Rudolf; Reichenbach, Stephan; Lehmann, Thomas (2023). Correction to: Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study. Osteoporosis international, 34(11), p. 1975. Springer-Verlag 10.1007/s00198-023-06887-4

[img]
Preview
 Text
Everts-Graber_OsteoporosInt_2023_correction.pdf - Published Version
Available under License Creative Commons: Attribution-Noncommercial (CC-BY-NC).
Download (419kB) | Preview

Item Type:

 Journal Article (Further Contribution)

Division/Institute:

 04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Rheumatology and Immunology
04 Faculty of Medicine > Department of Radiology, Neuroradiology and Nuclear Medicine (DRNN) > Institute of Diagnostic, Interventional and Paediatric Radiology
04 Faculty of Medicine > Pre-clinic Human Medicine > Department of Clinical Research (DCR)
04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Social and Preventive Medicine (ISPM)

UniBE Contributor:

 Everts-Graber, Judith, Bonel, Harald Marcel, Gahl, Brigitta, Reichenbach, Stephan

Subjects:

 300 Social sciences, sociology & anthropology > 360 Social problems & social services
600 Technology > 610 Medicine & health

ISSN:

 0937-941X

Publisher:

 Springer-Verlag

Language:

 English

Submitter:

 Pubmed Import

Date Deposited:

 21 Aug 2023 10:49

Last Modified:

 20 Feb 2024 14:15

Publisher DOI:

 10.1007/s00198-023-06887-4

Related URLs:

PubMed ID:

 37592150

BORIS DOI:

 10.48350/185548

URI:

 https://boris.unibe.ch/id/eprint/185548

Actions (login required)

Edit item Edit item
Provide Feedback